Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100049751Phase 4Not yet recruiting
Phase 4, open-label, single-arm trial of atropine in myopia, sponsored by Wuhan Hongshan Aier Eye Hospital. Primary endpoints: Corneal biomechanical parameters and Axial length. Planned start Aug 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100049751.